Search tips
Search criteria 


Logo of eidEmerging Infectious Diseases
Emerg Infect Dis. 2001 Nov-Dec; 7(6): 927–932.
PMCID: PMC2631893

Trichomonas vaginalis, HIV, and African-Americans.


Trichomonas vaginalis may be emerging as one of the most important cofactors in amplifying HIV transmission, particularly in African-American communities of the United States. In a person co-infected with HIV, the pathology induced by T. vaginalis infection can increase HIV shedding. Trichomonas infection may also act to expand the portal of entry for HIV in an HIV-negative person. Studies from Africa have suggested that T. vaginalis infection may increase the rate of HIV transmission by approximately twofold. Available data indicate that T. vaginalis is highly prevalent among African-Americans in major urban centers of the United States and is often the most common sexually transmitted infection in black women. Even if T. vaginalis increases the risk of HIV transmission by a small amount, this could translate into an important amplifying effect since Trichomonas is so common. Substantial HIV transmission may be attributable to T. vaginalis in African-American communities of the United States.

Full Text

The Full Text of this article is available as a PDF (46K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Cates W., Jr Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999 Apr;26(4 Suppl):S2–S7. [PubMed]
  • Wølner-Hanssen P, Krieger JN, Stevens CE, Kiviat NB, Koutsky L, Critchlow C, DeRouen T, Hillier S, Holmes KK. Clinical manifestations of vaginal trichomoniasis. JAMA. 1989 Jan 27;261(4):571–576. [PubMed]
  • Cotch MF, Pastorek JG, 2nd, Nugent RP, Hillier SL, Gibbs RS, Martin DH, Eschenbach DA, Edelman R, Carey JC, Regan JA, et al. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997 Jul;24(6):353–360. [PubMed]
  • Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, Goeman J, Behets F, Batter V, Alary M, et al. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993 Jan;7(1):95–102. [PubMed]
  • Sardana S, Sodhani P, Agarwal SS, Sehgal A, Roy M, Singh V, Bhatnagar P, Murthy NS. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Acta Cytol. 1994 Sep-Oct;38(5):693–697. [PubMed]
  • Kiviat NB, Paavonen JA, Brockway J, Critchlow CW, Brunham RC, Stevens CE, Stamm WE, Kuo CC, DeRouen T, Holmes KK. Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA. 1985 Feb 15;253(7):989–996. [PubMed]
  • Levine WC, Pope V, Bhoomkar A, Tambe P, Lewis JS, Zaidi AA, Farshy CE, Mitchell S, Talkington DF. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis. 1998 Jan;177(1):167–174. [PubMed]
  • Fouts AC, Kraus SJ. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis. 1980 Feb;141(2):137–143. [PubMed]
  • Kreiss J, Willerford DM, Hensel M, Emonyi W, Plummer F, Ndinya-Achola J, Roberts PL, Hoskyn J, Hillier S, Kiviat N. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis. 1994 Dec;170(6):1597–1601. [PubMed]
  • Hobbs MM, Kazembe P, Reed AW, Miller WC, Nkata E, Zimba D, Daly CC, Chakraborty H, Cohen MS, Hoffman I. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis. 1999 Aug;26(7):381–387. [PubMed]
  • Draper D, Donohoe W, Mortimer L, Heine RP. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J Infect Dis. 1998 Sep;178(3):815–819. [PubMed]
  • Wilkinson D, Abdool Karim SS, Harrison A, Lurie M, Colvin M, Connolly C, Sturm AW. Unrecognized sexually transmitted infections in rural South African women: a hidden epidemic. Bull World Health Organ. 1999;77(1):22–28. [PubMed]
  • Ghys PD, Diallo MO, Ettiègne-Traoré V, Yeboué KM, Gnaoré E, Lorougnon F, Kalé K, Van Dyck E, Brettegaard K, Hoyi YM, et al. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis. 1995 Nov;172(5):1371–1374. [PubMed]
  • ter Meulen J, Mgaya HN, Chang-Claude J, Luande J, Mtiro H, Mhina M, Kashaija P, Pawlita M. Risk factors for HIV infection in gynaecological inpatients in Dar es Salaam, Tanzania, 1988-1990. East Afr Med J. 1992 Dec;69(12):688–692. [PubMed]
  • Wiese W, Patel SR, Patel SC, Ohl CA, Estrada CA. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med. 2000 Mar;108(4):301–308. [PubMed]
  • Madico G, Quinn TC, Rompalo A, McKee KT, Jr, Gaydos CA. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol. 1998 Nov;36(11):3205–3210. [PMC free article] [PubMed]
  • van Der Schee C, van Belkum A, Zwijgers L, van Der Brugge E, O'neill EL, Luijendijk A, van Rijsoort-Vos T, van Der Meijden WI, Verbrugh H, Sluiters HJ. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J Clin Microbiol. 1999 Dec;37(12):4127–4130. [PMC free article] [PubMed]
  • Shuter J, Bell D, Graham D, Holbrook KA, Bellin EY. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis. 1998 Jul;25(6):303–307. [PubMed]
  • Bersoff-Matcha SJ, Horgan MM, Fraser VJ, Mundy LM, Stoner BP. Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. J Infect Dis. 1998 Oct;178(4):1174–1177. [PubMed]
  • Cu-Uvin S, Hogan JW, Warren D, Klein RS, Peipert J, Schuman P, Holmberg S, Anderson J, Schoenbaum E, Vlahov D, et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis. 1999 Nov;29(5):1145–1150. [PubMed]
  • Bunnell RE, Dahlberg L, Rolfs R, Ransom R, Gershman K, Farshy C, Newhall WJ, Schmid S, Stone K, St Louis M. High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors. J Infect Dis. 1999 Nov;180(5):1624–1631. [PubMed]
  • DeHovitz JA, Kelly P, Feldman J, Sierra MF, Clarke L, Bromberg J, Wan JY, Vermund SH, Landesman S. Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. Am J Epidemiol. 1994 Dec 15;140(12):1125–1134. [PubMed]
  • Fleisher JM, Senie RT, Minkoff H, Jaccard J. Condom use relative to knowledge of sexually transmitted disease prevention, method of birth control, and past or present infection. J Community Health. 1994 Dec;19(6):395–407. [PubMed]
  • Pabst KM, Reichart CA, Knud-Hansen CR, Wasserheit JN, Quinn TC, Shah K, Dallabetta G, Hook EW., 3rd Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit. Sex Transm Dis. 1992 Mar-Apr;19(2):88–91. [PubMed]
  • Wilson TE, Minkoff H, McCalla S, Petterkin C, Jaccard J. The relationship between pregnancy and sexual risk taking. Am J Obstet Gynecol. 1996 Mar;174(3):1033–1036. [PubMed]
  • Miller JM, Chambers DC, Miller JM. Infection with Trichomonas vaginalis in a black population. J Natl Med Assoc. 1989 Jun;81(6):701–702. [PMC free article] [PubMed]
  • Cotch MF, Pastorek JG, 2nd, Nugent RP, Yerg DE, Martin DH, Eschenbach DA. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group. Obstet Gynecol. 1991 Dec;78(6):1087–1092. [PubMed]
  • Barbone F, Austin H, Louv WC, Alexander WJ. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol. 1990 Aug;163(2):510–514. [PubMed]
  • Shafer MA, Sweet RL, Ohm-Smith MJ, Shalwitz J, Beck A, Schachter J. Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J Pediatr. 1985 Dec;107(6):974–981. [PubMed]
  • Hardy PH, Hardy JB, Nell EE, Graham DA, Spence MR, Rosenbaum RC. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet. 1984 Aug 11;2(8398):333–337. [PubMed]
  • Bell TA, Farrow JA, Stamm WE, Critchlow CW, Holmes KK. Sexually transmitted diseases in females in a juvenile detention center. Sex Transm Dis. 1985 Jul-Sep;12(3):140–144. [PubMed]
  • McCormack WM, Evrard JR, Laughlin CF, Rosner B, Alpert S, Crockett VA, McComb D, Zinner SH. Sexually transmitted conditions among women college students. Am J Obstet Gynecol. 1981 Jan 15;139(2):130–133. [PubMed]
  • Osborne NG, Grubin L, Pratson L. Vaginitis in sexually active women: relationship to nine sexually transmitted organisms. Am J Obstet Gynecol. 1982 Apr 15;142(8):962–967. [PubMed]
  • Ris HW, Dodge RW. Trichomonas and yeast vaginitis in institutionalized adolescent girls. Am J Dis Child. 1973 Feb;125(2):206–209. [PubMed]
  • Ipsen J, Feigl P. A biomathematical model for prevalence of Trichomonas vaginalis. Am J Epidemiol. 1970 Feb;91(2):175–184. [PubMed]
  • Rosenberg MJ, Davidson AJ, Chen JH, Judson FN, Douglas JM. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health. 1992 May;82(5):669–674. [PubMed]
  • Wilson TE, Minkoff H, DeHovitz J, Feldman J, Landesman S. The relationship of cocaine use and human immunodeficiency virus serostatus to incident sexually transmitted diseases among women. Sex Transm Dis. 1998 Feb;25(2):70–75. [PubMed]
  • Sorvillo F, Kovacs A, Kerndt P, Stek A, Muderspach L, Sanchez-Keeland L. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention. Am J Trop Med Hyg. 1998 Apr;58(4):495–500. [PubMed]
  • Niccolai LM, Kopicko JJ, Kassie A, Petros H, Clark RA, Kissinger P. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex Transm Dis. 2000 May;27(5):284–288. [PubMed]
  • Krieger JN, Verdon M, Siegel N, Critchlow C, Holmes KK. Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis. 1992 Dec;166(6):1362–1366. [PubMed]
  • Borchardt KA, al-Haraci S, Maida N. Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin Med. 1995 Dec;71(6):405–406. [PMC free article] [PubMed]
  • Joyner JL, Douglas JM, Jr, Ragsdale S, Foster M, Judson FN. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex Transm Dis. 2000 Apr;27(4):236–240. [PubMed]
  • Saxena SB, Jenkins RR. Prevalence of Trichomonas vaginalis in men at high risk for sexually transmitted diseases. Sex Transm Dis. 1991 Jul-Sep;18(3):138–142. [PubMed]
  • Grady WR, Tanfer K. Condom breakage and slippage among men in the United States. Fam Plann Perspect. 1994 May-Jun;26(3):107–112. [PubMed]
  • Stewart DL, DeForge BR, Hartmann P, Kaminski M, Pecukonis E. Attitudes toward condom use and AIDS among patients from an urban family practice center. J Natl Med Assoc. 1991 Sep;83(9):772–776. [PMC free article] [PubMed]
  • Aral SO, Mosher WD, Cates W., Jr Vaginal douching among women of reproductive age in the United States: 1988. Am J Public Health. 1992 Feb;82(2):210–214. [PubMed]
  • Scholes D, Stergachis A, Ichikawa LE, Heidrich FE, Holmes KK, Stamm WE. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol. 1998 Jun;91(6):993–997. [PubMed]
  • Grosskurth H, Mosha F, Todd J, Mwijarubi E, Klokke A, Senkoro K, Mayaud P, Changalucha J, Nicoll A, ka-Gina G, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995 Aug 26;346(8974):530–536. [PubMed]
  • Schwebke JR, Morgan SC, Pinson GB. Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis. J Clin Microbiol. 1997 Jun;35(6):1618–1619. [PMC free article] [PubMed]
  • Mayta H, Gilman RH, Calderon MM, Gottlieb A, Soto G, Tuero I, Sanchez S, Vivar A. 18S ribosomal DNA-based PCR for diagnosis of Trichomonas vaginalis. J Clin Microbiol. 2000 Jul;38(7):2683–2687. [PMC free article] [PubMed]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention